Are there specific genetic markers that make gastrointestinal stromal tumors more likely to return?
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the gastrointestinal tract. Whether a GIST returns after treatment depends partly on its genetic markers. The most important markers are mutations in the KIT and PDGFRA genes, which are found in most GISTs. Certain mutations, especially in KIT, are linked to a higher risk of recurrence. Additionally, recent research has identified inherited genetic variants that may increase the chance of GIST coming back.
What the research says
Most GISTs have mutations in the KIT or PDGFRA genes, which drive tumor growth. These mutations are also key for predicting recurrence risk. For example, KIT mutations are common in high-risk GISTs, and tumors with certain KIT mutations may be more aggressive 6. A large genome-wide study found that a specific inherited variant near the SLC6A18 and TERT genes was more common in GIST patients whose tumors also had KIT mutations. Carriers of this variant with KIT-mutant tumors had a significantly worse survival (hazard ratio 4.06), meaning their tumors were more likely to recur or progress 4. This suggests that both the tumor's own mutations and the patient's inherited genetics can influence recurrence risk. Treatment with imatinib, a drug that blocks KIT and PDGFRA, is standard for high-risk GIST. A study showed that extending imatinib therapy beyond 3 years improved 5-year relapse-free survival (84% vs. 74% for shorter treatment), indicating that genetic risk factors can be managed with longer therapy 3. However, not all GISTs have KIT mutations; about 5% are KIT-negative, and these often have PDGFRA mutations, which may behave differently 6.
What to ask your doctor
- Has my tumor been tested for KIT and PDGFRA mutations? What type of mutation was found?
- Based on my tumor's genetic markers, what is my estimated risk of recurrence?
- Would I benefit from longer adjuvant imatinib therapy (beyond 3 years) given my genetic profile?
- Should I consider genetic testing for inherited variants that might affect my recurrence risk?
- How often should I have follow-up scans to monitor for recurrence?
This question is drawn from common patient questions about Gastroenterology and answered using cited medical research. We do not provide individualized advice.